/PRNewswire/ Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and full year ended December 31, 2021,.
Aterian signed an asset backed credit facility with MidCap Financial Trust (“MidCap”), which is managed by a subsidiary of Apollo Global Management, Inc. The credit facility has a three year term and gives Aterian access to up to $50 million in total credit, consisting of $40 million in commitments with an accordion facility of an additional $10.
ABL Advisor provides a unique view of the world of commercial equipment finance by focusing content and resources on both sides of the equipment finance spectrum – the lender and lessor as well as the borrower and lessee. Our goal is to meet the editorial content needs of both participants in an equipment finance transaction resulting in greater opportunities for long-term relationships between the two parties.
– Exicure will reduce its workforce by approximately 50%, along with the implementation of other cost-cutting measures –
– Company to wind down immuno-oncology program cavrotolimod. | December 10, 2021
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus -Exicure will reduce. | December 10, 2021